• Profile
Close

Clinical outcome of ampullary carcinoma: Single cancer center experience

Journal of Oncology May 07, 2019

Al-Jumayli M, et al. - Fifty-four patients who had undergone endoscopic resection or pancreaticoduodenectomy (PD) for Ampullary cancer at KU Cancer Center were retrospectively analyzed for factors associated with overall survival (OS) and for findings that may aid in selecting the modality and regimen of adjuvant therapy [adjuvant chemotherapy (CT) or chemoradiation therapy (CRT)] for resected Ampullary carcinoma. Efforts in rare malignancies such as Ampullary cancer remain very challenging with a clear lack of an evidence-based standard of care treatment paradigm. Researchers observed poor OS in correlation to high-risk features like peripancreatic extension (16%) and perineural invasion (26%). As per finding, patients with high-risk disease may display improvement in survival on receiving adjuvant therapies such as CT or CRT. However, no standardized regimen exists for the treatment of Ampullary cancer.
Full text available Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay